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Abstract
The “radiation issue” is the need to consider possible deterministic effects (e.g., skin injuries) and long-term cancer
risks due to ionizing radiation in the risk-benefit assessment of diagnostic or therapeutic testing. Although there
are currently no data showing that high-dose medical studies have actually increased the incidence of cancer, the
“linear-no threshold” model in radioprotection assumes that no safe dose exists; all doses add up in determining
cancer risks; and the risk increases linearly with increasing radiation dose. The possibility of deterministic effects
should also be considered when skin or lens doses may be over the threshold. Cardiologists have a special mission
to avoid unjustified or non-optimized use of radiation, since they are responsible for 45% of the entire cumulative
effective dose of 3.0 mSv (similar to the radiological risk of 150 chest x-rays) per head per year to the US
population from all medical sources except radiotherapy. In addition, interventional cardiologists have an exposure
per head per year two to three times higher than that of radiologists. The most active and experienced
interventional cardiologists in high volume cath labs have an annual exposure equivalent to around 5 mSv per
head and a professional lifetime attributable to excess cancer risk on the order of magnitude of 1 in 100.
Cardiologists are the contemporary radiologists but sometimes imperfectly aware of the radiological dose of the
examination they prescribe or practice, which can range from the equivalent of 1-60 mSv around a reference dose
average of 10-15 mSv for a percutaneous coronary intervention, a cardiac radiofrequency ablation, a multi-detector
coronary angiography, or a myocardial perfusion imaging scintigraphy. A good cardiologist cannot be afraid of life-
saving radiation, but must be afraid of radiation unawareness and negligence.
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Radiation in cardiology: regulatory framework
and missing evidences
Almost 10 years ago, the “radiation issue” was raised,
which refers to the need to include long-term cancer
risks due to ionizing radiation in the risk-benefit assess-
ment of diagnostic or therapeutic testing. This issue is
obviously relevant from the individual patient’s [1], soci-
etal [2] and bioethical [3] perspective, and clearly
stemmed from standard radioprotection knowledge
already at that time well-embedded in Euratom law [4]
and European Commission medical imaging guidelines
[5]. It was initially raised in the critical area of non-inva-
sive diagnosis of coronary artery disease, where the dose
of 10 million stress imaging future procedures per year,
the high dose of perfusion imaging and the availability
of competitive non-ionizing techniques pose special pro-
blems of avoidable long-term cancer risk [1,6]. However,
at that time this position was largely perceived by peers
as being motivated by an attempt of non-radiologist
imaging specialists to expand or defend their own ima-
ging market shares [7]. In the last 10 years, things have
changed. For a long time ignored by the mainstream
imaging and cardiology community, the “linear-no
threshold” model in radioprotection assumes that no
safe dose exists; the risk increases linearly with increas-
ing radiation dose; all doses add up in determining can-
cer risk. This model was more generally accepted as
epidemiological evidence matured, and was re-endorsed
by concordant statements of the US National Academy
of Sciences Biological Effects of Ionizing Radiation Com-
mittee (2006), International Commission on Radiological
Protection (2007), and United Nations Scientific Com-
mittee on the Effects of Atomic Energy (2008) [8-10].
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doses of radiation were less harmful and possibly even
beneficial was abandoned [8-10] although there are cur-
rently no data showing that high dose medical studies
have actually increased the incidence of cancer and the
full validation of the linear no-threshold model is still
lacking in the low dose range (below 100 mSv) [7]. In
particular, the evidence gaps are that radiation data
gathered from atomic bombings were whole body doses
that occurred in a brief period of time, not comparable
to small medical doses applied over days or years. Radia-
tion given in fractionated doses as happens with medical
t e s t i n gi sp r o b a b l yl e s sh a r m f u lt h a nas i n g l ed o s e
applied to the same organ. Many of the long-term
effects, including cancer, become manifest 20 or more
years after the exposure, but diagnostic medical studies
are more frequently performed in elderly patients with
co-morbidities, less likely to live long enough to develop
a radiation-induced illness [7].
In spite of these evidence gaps, in 2005 cardiology
imaging guidelines accepted in principle that the risk-
benefit assessment balance should include long-term
cancer risks on the risk side [11]. In 2005, the interven-
tional cardiology guidelines of the American College of
Cardiology Foundation emphasized that “the responsibil-
ity of all physicians is to minimize the radiation injury
hazard to their patients, to their professional staff and to
themselves” [12]. In 2009, the AHA Science Advisory at
last delivered the reference doses of common cardiology
examinations [13], and in 2010 the ACC committee also
overtly expressed the need for appropriate and opti-
mized use of radiation techniques in cardiology [14]. It
is now generally recognized that all physicians make
every effort to see that “each patient should get the
right imaging exam, at the right time, with the right
radiation dose”, as suggested by the FDA in the 2010
initiative to reduce unnecessary radiation exposure from
medical imaging [15]. Attention to radiation protection
i so n ea s p e c t-a n dn o tt h el e a s ti m p o r t a n t– of good
practice of medicine, and in particular cardiology.
Cardiologist, the contemporary radiologist
ICRP introduced the quantity effective dose (mSv) for
occupational exposures but it is more and more used
in medicine as an approach to estimate radiological
risk [9]. ICRP recognizes that effective doses can be of
value for comparing the relative dose from different
diagnostic procedures and for comparing the use of
similar technologies and procedures, provided that the
referent patient populations are similar with regard to
age and sex [9]. Medical radiation from x-rays and
nuclear medicine is the largest manmade source of
radiation exposure in western countries, accounting for
a mean effective dose of 3.0 mSv per head per year,
equivalent to the radiological risk of 150 chest x-rays
(Figure 1) [16]. Of these, one-fourth come from
nuclear medicine (g-rays) and the remaining from radi-
ology (x-rays). Of the 150 chest x-rays from medical
radiation except radiotherapy, almost one-half come
from cardiology procedures. In particular, nuclear car-
diology accounts for 57% of all nuclear medicine pro-
cedures and 85% of the entire cumulative effective
dose due to nuclear medicine, whereas cardiac radiol-
ogy accounts for about 30% of the exposure due to x-
ray procedures (Figure 2) [17]. Exact figures can
depend upon the specific country, the radiological
year, and uncertainties in allocating to a specific sub-
specialty some examinations, such as chest CT. For
instance, in Germany nuclear cardiology accounted for
40% of the overall collective dose from nuclear medi-
cine in the years 1996-2000 [18] and cardiovascular
radiology for around 50% of x-rays dose in the radiolo-
gical year 2005 [19]. Overall there is little doubt that
cardiology makes a dominant contribution to global
radiological warming. The reasons are simple: 1) cardi-
ology imaging examinations are very common, with
about 1 million PCI, 10 million MPI’s and 10 million
MDCT’s per year in the US alone; 2) each procedure
involves a very large radiation exposure, which may
range from 5 to 57 mSv and more, around an average
reference dose of 10-15 mSv for a percutaneous coron-
ary intervention, a cardiac radiofrequency ablation, a
multi-detector coronary angiography or a myocardial
perfusion imaging scintigraphy [13,20-22]. In particu-
lar, effective doses of invasive cardiology procedures
vary widely by a factor of 10 (Table 1), with more
complex procedures such as dilation of chronic total
coronary occlusion [23] or transthoracic aortic valve
replacement [24] or endovascular thoraco-abdominal
aneurysm repair [25] which may easily exceed the
effective dose of 100 mSv. In addition, interventional
cardiologists have an exposure per head per year two
to three times higher than that of radiologists and
their exposure has increased steadily in the past 5
years [26,27]. The most active and experienced of
interventional cardiologists in high volume catheteriza-
tion laboratories have an annual exposure equivalent
to around 5 mSv per year, and a professional lifetime
attributable excess cancer risk of 1 in 100 [8,28]. For
both patients and doctors, the risk is cumulative,
meaning that when several test or procedures are per-
formed, dose is added to dose and risk to risk. The
cumulative exposure per patient [17,29,30] per pro-
blem [31], during a single admission [32] may well
reach values around a cumulative exposure of 100
mSv.
According to current risk estimates if 100 subjects are
exposed to 100 mSv, 42 will have a spontaneous cancer
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radiation-induced cancer (with a range of uncertainty of
1 in 30-1 in 300): Figure 3[8]. This is an average risk,
assuming a sex and age distribution similar to that of
the entire US population [8]. For any given dose, the
risk is 3-4 times higher in children than in adults, 50%
l o w e ri na n8 0 - y e a ro l dc o m p a r e dt oa5 0 - y e a ro l ds u b -
ject, and 38% higher in females than in males. These
estimates do have a considerable margin of uncertainty,
with a 2 to 3 confidence intervals [8].
Dose optimization is essential to minimize both the
patient’sa n dd o c t o r ’s risk in the catheterization
laboratory [33]. Decreasing patient dose will result in
a proportional decrease in scatter dose to the operator
[34]. Therefore, techniques that reduce patient dose
will generally also reduce the occupational dose [35].
This is a “win-win” situation: the doctor and the
patient both benefit (Table 2). Protective shielding is
also essential for operator protection. It includes
structural (architectural wall) shielding, mobile shield-
ing (with ceiling suspended leaded plastic and table-
suspended drapes) and personal shielding (with lead
aprons, thyroid collars and leaded glasses). However,
t h em o s te f f e c t i v es h i e l d i n gi st h eo p e r a t o r ’s
knowledge of radiation risk [36] - which is often sub-
optimal [37-39].
Tissue reactions in cardiologists and cardiology
patients
There are two main biological effects of radiation: sto-
chastic effects, which include carcinogenetic and genetic
effects, and tissue reactions (previously called determi-
nistic effects), which cause an immediate and very pre-
dictable change to the tissue [40]. Tissue reactions
happen when the dose exceeds a specific threshold. The
two most frequent examples of tissue reactions (deter-
ministic effects) of cardiological interest are cataract for-
mation (in doctors) and skin injury (in patients).
Cataract, or opacification of the lens, is often asso-
ciated with visual impairment and may be classified into
three main categories: nuclear, cortical, and posterior
subcapsular, according to their anatomic location [41].
Of the three major categories of age-related cataracts,
posterior subcapsular is the least common but it is the
one most frequently associated with ionizing radiation
exposure. Because of their location along the lens’ visual
axis, relatively minor posterior subcapsular cataracts can
have great impact on vision. The estimated eye dose is
Figure 1 Medical and natural sources of radiation. Modified from Picano E, BMJ, 2004, ref. 2 updated with Mettler et al, Health Physics, 2009,
ref. 16. The effective dose of 1 mSv is equivalent to 50 chest x-rays.
Picano and Vano Cardiovascular Ultrasound 2011, 9:35
http://www.cardiovascularultrasound.com/content/9/1/35
Page 3 of 13around 0.5 mGy/procedure, in cardiac catheterization
laboratories when no eye protection is used. Until
recently, the dose threshold for radiation-induced lens
opacities were considered 2 Gy for a single dose or 5 Gy
for fractionated dose [19]. However, several epidemiolo-
gical studies among Chernobyl clean-up workers, A-
bomb survivors, astronauts, residents of contaminated
buildings, and surveys of staff in interventional rooms
indicate that there is an increased incidence of lens opa-
cities at doses below 0.5 Gy and even suggests a sto-
chastic hypothesis (non-threshold effect) [42]. Whether
deterministic or stochastic in nature, lens opacities have
been documented in up to 50% of interventional cardi-
ologists [43]. The reasons for this high prevalence are
three fold: first is that operator’se y e sa r ee x p o s e dt o
scattered x-rays; second (avoidable) is the frequent fail-
ure of some cardiologists to use protective leaded eye-
wear [43]; and probably third, that the permitted
occupational dose limits were too high even to provoke
am e n t a la l e r t .O nA p r i l2 1 ,2 0 1 1 ,I C R Ps l a s h e dt h e
earlier dose limit of 150 mSv in a year for the lens of
the eye to the present 20 mSv in a year, averaged over a
defined period of five years, with no single year exceed-
ing 50 mSv [44].
When fluoroscopic procedures require more than 20
minutes using high-contrast fluoroscopy mode or 60
minutes in low level fluoroscopy, there may be a possi-
bility of patient skin injuries. Significantly, injuries are
not limited solely to the use of older equipment, but
can occur when poor technique is employed with newer
and digital equipment capable of delivering higher doses
[45]. Radiation burns remain asymptomatic and often go
unrecognized [46]. This is quite contrary to the familiar
thermal burn, which is associated with a recognizable
source of heat and instantaneous pain. They usually
occur on the patient’s back (where the x-rays are deliv-
ered) and since they develop several weeks after the pro-
cedure their association with cardiac interventions may
not be considered, and many severe cases come to light
through litigation. A case is filed in US courts every 4-5
Figure 2 The relative contribution of cardiovascular examinations to overall exposure from nuclear medicine (left panel) referred to
radiological years 2006. The nuclear cardiology contribution of about 32 chest x-rays per year is matched by the 33 chest x-rays per year from
cardiac radiology, for a grand total of 65 chest x-rays, corresponding to 43% of the total exposure of the average US citizen. Redrawn and
adapted from ref 16 and 17.
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In almost every country around the world, reporting sig-
nificant radiological incidents and accidents that occur
during, or as a direct result of using ionizing radiation
for a medical procedure is a legal requirement. But in
practice, such reporting hardly ever occurs. Very few
countries have a functioning reporting system because
no one wants to be blamed for patients’ radiation
r e l a t e db u r n s ,h a i rl o s so rs k i ni n j u r y .H o w e v e r ,t h i s
information is essential if lessons are to be learned. The
IAEA has set up its own international reporting system
called SAFRAD (SAFety in RADiological procedures).
Because the SAFRAD system is anonymous and the
IAEA will not supply identifiable data to governmental
authorities or other third parties, there will be no fear of
blame [48].
The future direction of radioprotection in
cardiology
We should make every effort to bring the cardiology
community from an evidence-poor to an evidence-rich
environment in the specific field of radioprotection in
cardiology (Table 3). Further data are needed, especially
i nt h el o wd o s er a n g e( < 1 0 0m S v ) .B E I RV I Il i s t e d
among top-research needs “future medical imaging stu-
dies”, including studies of infants who undergo diagnos-
tic exposures [8]. Theoretically, such studies will be a
tough challenge, since the extra risk of dying from a sin-
gle CT scan exposure is estimated to be 1 in 1000, and
about 40% of the population eventually have some kind
of cancer and 20% of the population will die from it. It
has been calculated that an epidemiological study of 5
million people would be required to quantify directly
the risk of cancer from exposure of 10 mSv or less [49].
Since the relation linking the required sample size and
the exposure dose is hyperbolic, a substantially lower
sample size is required if a cumulative diagnostic expo-
sure (of all ionizing tests) is considered (now easily in
the range of 100 mSv), if a pediatric or young popula-
tion is evaluated (in whom fourfold higher effects than
an adult are expected for the same radiation dose), and
if genetically vulnerable populations are studied (in
whom 2 to 3 times the effects of a given dose can be
observed in comparison with a genetically resistant
population) [50]. Data mining on this very relevant issue
has already begun, and in a population of 82,861
patients admitted with acute myocardial infarction,
there was a 3% increase in cancer over a mean follow-
Table 1 Standard reference doses of common cardiological examinations
Diagnostic procedures, ref. Effective
dose (mSv)
Equivalent nmber of PA chest
radiographs (each 0.02 mSv)
Approximate equivalent period of natural
background radiation (years)
CONVENTIONAL RADIOGRAPHY
Chest x-ray (PA), 13 0.02 1 0.008
INVASIVE RADIOLOGY
Diagnostic coronary angiography, 13 7 (2-16) 350 (100-800) 2.9
PCI, 13 15 ( 7-57) 750 (350-2800) 6.3
Cardiac radiofrequency ablation, 13 15 (7-57) 750 (350-2800) 6.3
Dilation chronic coronary occlusion, 23 81 (17-194) 4050 (850-9600) 33.7
Head and/or neck angiography, 20 5 (1-20) 250 2.1
Thoracic angiography of pulmonary
artery or aorta, 20
5 (4-9) 250 2.1
Abdominal angiography or aortography,
20
12 (4-48) 600 5.0
Aortic valvuloplasty, 24 39 1950 16.2
Endovascular thoraco-abdominal
aneurysm repair procedures, 24
76-119 3800-5950 31.6-49.5
COMPUTED TOMOGRAPHY
64-slice coronary CTA, 13 15 (3-32) 750 (150-1600) 6.3
Coronary calcium CT,13 3 (1-12) 150 (50-600) 1.2
NUCLEAR CARDIOLOGY
PET F-18 FDG (viability), 13 14 700 5.8
Thallium stress/rest reinjection, 13 41 2050 17
Sestamibi (1 day) stress-rest, 13 9 450 3.7
Rubidium-82, 13 5 250 2.1
N-13 ammonia stress-rest, 22 3 150 1.25
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about one (red star) out of 100 people would likely develop solid cancer or leukemia from a single exposure of 100 mSv above
background. About 42 additional people (yellow circles) in the same group would be expected to develop solid cancer or leukemia from other
causes in a lifetime. Roughly half of these cancers would result in death. Modified and adapted from Committee to Assess Health Risks from
Exposure to Low Levels of Ionizing Radiation; Nuclear and Radiation Studies Board, Division on Earth and Life Studies, National Research Council
of the National Academies. Health Risks From Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Washington, DC: The National
Academies Press; 2006 (ref. [8]
Table 2 Factors modulating doses in cardiac catheterization lab
Lower doses Higher doses
OPERATOR-
DEPENDENT
Operator background Expert Beginner
Cath-lab director Radiation aware and conscious Not radiation aware and conscious
Written records Includes KAP Omits KAP
Arterial Approach Trans-Femoral Trans-Radial
Pulsed Fluoroscopy Low rate (12.5/s) High rate (25/s)
Patient to image intensifier or flat panel
distance
As small as possible Large
Ventriculography No Yes
Cine-duration Short Long
Magnified views Few Many
Projection Ant, RAO Lateral, LAO
Dose audit Yes No
PATIENT-DEPENDENT Body habitus Lean Obese
Coronary lesion to be dilated Simple and single Complex and multiple
Arrhythmic lesion to be ablated Supraventricular tachycardia Atrial fibrillation, ventricular
tachycardia
TECHNOLOGY X-ray system Inspected for QC and
maintained
Not tested for QC and not
maintained
KAP = Kerma Area Product; LAO = Left anterior oblique projection; RAO = Right anterior oblique projection; QC = quality control.
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radiation [51]. Another BEIR research need of interest
to cardiologists regards “future occupational radiation
studies”, which can certainly include highly exposed (in
the last 2 to 3 decades) interventional cardiologists, a
population well suited to assess effects of long-term,
low-level radiation exposure in humans [36].
A suggested alternative to the epidemiological
approach is the biodosimetry approach, applicable to
both cardiological patients and professionally exposed
cardiologists [4]. The most suitable biodosimeter for
cancer is the assay of double-stranded DNA breaks,
micronuclei or chromosome aberrations in circulating
peripheral lymphocytes, or gamma-H2AX foci for sin-
gle-stranded DNA damage. In this way, it is easier to
“see” in a more tangible way the direct effects of radia-
tion exposure on proximal markers of cancer, which are
intermediate end-points and long-term predictors of dis-
ease [52,53]. In fact, an acute diagnostic or therapeutic
x-ray exposure in the 10- to 50 mSv range - well below
the threshold of epidemiological evidence linking radia-
tion to cancer - is associated with a 15% increase in
micronuclei in adults after invasive cardiovascular inter-
ventions [54], a 100% long-term increase in children
treated for congenital heart disease 15 to 20 years after
the exposure [55] and a 50% increase in interventional
cardiologists after 10 to 20 years of catheterization
laboratory exposure with cumulative professional dose
i nt h e3 0t o1 0 0m S vr a n g e[ 5 6 ] .C h r o n i c a l l ye x p o s e d
interventional cardiologists also show altered redox bal-
ance and increased susceptibility to apoptotic induction
in lymphocytes [57]. A clear recommendation of
UNSCEAR 2009 is to pay more attention “to other non-
cancer disease entities, in addition to circulatory dis-
eases”, encouraging “future epidemiological studies
designed to assess clinical and subclinical endpoints, as
well as biomarkers, since this information is more likely
to lead to insights” [10]. The challenging field ahead is
to translate, for both patients and professionally exposed
doctors, the generic population risk obtained from epi-
demiological age-and gender-based risk into a persona-
lized risk [40]. Several genetic, environmental and
dietary variables can affect the variability of damage
observed to any given level of radiation, and current
research is targeted at shifting epidemiology estimates to
personalized measures of DNA and chromosomal
damage, focused on identifying inter-individual differ-
ences that could modulate radiation risks in order to
obtain better estimates of the extent of damage. For
instance, radiation-associated chromosomal damage in
interventional cardiologists is amplified by smoking and
by genetic polymorphism of genes involved in DNA
repair [58]. If the risk is personalized, it will be easier to
implement targeted predictive and chemo-preventive
strategies [59], since it is now proven that a variety of
biological response modifiers can modulate tissue reac-
tions in many tissues. These include antioxidants, radi-
cal scavengers, anti-inflammatory drugs, angiotensin
converting enzyme inhibitors, growth factors and cyto-
kines (Figure 4). In many cases these give dose modify-
ing factors of 1.1 to 2, indicating the potential for
increasing threshold doses in known exposure cases. In
contrast, there are agents which enhance radiation
responses, notably other cytotoxic agents such as anti-
metabolites, alkylating agents, antiangiogenic drugs, and
antibiotics, as well as genetic and comorbidity factors
[40].
Other important cardiology-based lines of research
will be technological advancement to reduce the effec-
tive dose in different fields, from nuclear cardiology to
CT, from interventional cardiology to cardiac radiofre-
quency ablation (Figure 5). For instance, the recent
emphasis on radiation exposure due to CT scanning has
engendered a competitive effort on the part of manufac-
turers (the commercial “dose war”, after the “slice war”)
to reduce the dose while still providing diagnostic
images. As a result, cardiac CT angiography can now be
performed with high-quality images with a mean
Table 3 Action to be taken on radiological protection in cardiology: what can be done
1. Epidemiological data mining in children (especially congenital heart disease with history of intensive interventional procedures)
2. Epidemiological data mining in adults (ischemic heart disease or arrhythmias with history of intensive interventional procedures)
3. Epidemiological data mining in contemporary interventional cardiologists and staff
4. Prospective radiobiology and genetic studies in acutely exposed patients
5. Prospective radiobiology and genetic studies in chronically exposed interventional cardiologist
6. Development of targeted chemo-preventive strategies in high-risk groups (patients and cardiologists)
7. Evaluation of non-cancer (atherosclerosis, reproductive, etc) effects by appropriate biomarkers in exposed staff and patients
8. Development of informatic support to effective dose recording, radiologic risk assessment and imaging appropriateness
9. Development of innovative devices and procedures for radiological protection of patients and doctors
10. Social communication campaign to doctors and patients
Modified and adapted from recommendations of BEIR VII (points 1 to 6); UNSCEAR (point 7); President’s Cancer Panel Report (points 8 to 10).
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Substantial dose reduction can also be achieved in
nuclear myocardial perfusion imaging abandoning Thal-
lium (25 mSv+) for Sestamibi (10 mSv), by new recon-
struction algorithms, stress-only protocols, and by
implementing semiconductor detectors into latest- gen-
eration gamma cameras allowing massive scan shorten-
ing or dose reduction [22]. Research is currently
addressing the issue of finding a way to improve the
unacceptably high rate of inappropriate cardiac imaging
testing [61], still around 30% for most common ionizing
examinations such as myocardial perfusion scintigraphy
or cardiac CT [62,63]. Last but not least, substantial
effort will be directed to increasing the currently subop-
timal radiological awareness of cardiologists, prescribing
doctors and patients, since awareness is the best shield
from unnecessary medical radiation exposure. Both FDA
[15] and the President’s Cancer Panel [64] recommend
social communication to patients and doctors. The pat-
tern of this communication might be modelled on the
“Image Gently and Step Lightly Campaign”,w h i c hi n
the US addressed the issue of radiological responsibility,
focusing on the risks of unnecessary and excessive medi-
cal radiation from interventional radiology administered
to our pediatric patients [65]. User-friendly informatic
support or mobile platforms might be helpful for this
purpose [66]. Another highly effective, and possibly the
best, way to improve the radiological awareness within
the cardiology community is to involve cardiologists in a
proactive role on studies evaluating the health effects of
radiation on themselves. The Multispecialty Occupa-
tional Health Group (MOHG) undertook a cohort mor-
tality study comparing cancer and other serious disease
outcomes (including cardiovascular diseases and catar-
acts) in 44,000 physicians performing fluoroscopically
guided procedures (including interventional cardiolo-
gists, radiologists, neuroradiologists and others) and in
12,000 non-interventional radiologists with risks in
101,000 physicians who are unlikely to be occupationally
exposed to radiation (e.g., family physicians or psychia-
trists) [67]. Member organizations of the MSOHG
include the Society of Cardiac Angiography and
Figure 4 The population risk is in reality due to the average of a spectrum of risks, with higher risks being for instance associated
with mutation of genes involved in DNA repair and with the presence of other environmental mutagens such as smoking.
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Page 8 of 13Intervention, Society of Interventional Radiology, Heart
Rhythm Society, American College of Radiology, Ameri-
can College of Cardiology, Society of Neurointervention
Surgery, American Association of Physicists in Medicine,
and Society of Invasive Cardiac Professionals. The
MSOHG is collaborating with experts in occupational
health, epidemiology, and radiation effects from the Uni-
ted States Navy and the Radiation Epidemiology Branch
of the National Cancer Institute, to perform epidemiolo-
gical studies addressing the fundamental questions
important to all those working in such an environment.
In Italy, the Healthy Cath Lab study is organized by
the Italian National Research Council with endorsement
of Italian Society of Invasive Cardiologists, and is
designed by interventional cardiologists on interven-
tional cardiologists and for interventional cardiologists
(http://www.gise.it.healthycathlab). The Italian study
population will consist of 500 exposed (high, medium,
and low exposure) interventional cardiologists and staff
(technicians and staff) and 500 unexposed controls (clin-
ical cardiologists and nurses). With this limited sample
size, the detection of potentially increased health risks
remains difficult through the epidemiological approach.
Therefore, as an alternative to the epidemiological
approach the Healthy Cath Lab study will assess non-
cancer health effects through “early warning signs”,
which evaluate initial damage through surrogate end-
points which are easy to measure, non-invasive, and are
able to identify long-term risk for subsequent clinically
overt disease, such as micronuclei as a surrogate for
cancer, telomere length for atherosclerosis and aging,
and so on [53].
Risk estimates: uncertainties and controversies
Cardiologists have to rely on the best available esti-
mates of risk, and at present such evidence is repre-
sented by the linear-no-threshold model presented by
BEIR VII [8]. Other organizations are basically suppor-
tive of this model, including the International Commis-
sion on Radiological Protection (2007) [9,40], United
Nations Scientific Committee on the Effects of Atomic
Radiation (2008) [10], National US Council of Radia-
tion Protection and Measurements (2001) [68] and UK
National Radiological Protection Board (1995) [69].
Other organizations such as the Health Physics Society
believe (2004) that LNT is an oversimplification and
risk estimates should not be used at < 50 mSv [70].
The French Academy of Sciences (2004) and American
Nuclear Society (2001) hold that LNT overestimates
risk [71,72].
Figure 5 The radiological dose-sparing cascade provided by technical and cultural upgrading in four critical areas of cardiology:
Myocardial Perfusion Imaging (MPI, from thallium to sestamibi tracers, from standard to triple-headed gamma camera, and from gamma camera
to PET imaging with N-13 ammonia), MDCT (Multi-Detector Computed Tomography, from retrospective to prospective triggered techniques with
dose modulation), interventional cardiology (with 90% dose reduction simply achieved through radioprotection training) and cardiac
radiofrequency ablation (moving from standard fluoroscopy to near-zero exposure with non-fluoroscopy navigation techniques).
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radiobiological dispute and should simply accept and
apply in their daily practice the LNT model and BEIR
risk estimates which are incorporated into law in many
countries. The BEIR VII risk models were developed
based on a comprehensive review of the world literature
on radiation epidemiology, and extensive efforts were
made to compose a highly expert committee and avoid
conflicts of interest. The conclusion is that the LNT
best fits the data and should remain the standard for
radiation protection although still suffering from sub-
stantial indetermination in the low dose range (Figure
6). The risk of cancer also evaluated by BEIR VII (or
ICRP) needs to be weighed against the potential benefits
of any radiation-based diagnostic or therapeutic proce-
dure [73]. In addition, the lively debate on the existence
of a threshold < 50-100 mSv is de facto outdated by the
high levels of dose exposure in contemporary patients,
who easily cross the threshold in one episode of care, or
with a single exam [29-32]. A more substantial
uncertainty relates to the entity of cancer risk for any
given dose, since both BEIR VII and ICRP apply a
reduced estimate of cancer risk based on risk coeffi-
cients derived from the Japanese atomic bomb survivors,
that is, from persons with acute, high-dose exposures.
Such acute, high dose estimates are then combined with
a “dose and dose-rate effectiveness factor” (DDREF).
Values for this correction factor have mainly been
deduced from experiments with laboratory animals and
from radiobiological measurements. Specifically, the
ICRP-derived estimates of the excess cancer risk after
low-dose exposures and after exposures with higher
doses but low-dose rates by reducing the corresponding
risk value for the atomic bomb survivors by a DDREF of
2.0 [9]. The BEIR VII Committee of the US National
Research Council used a DDERF of 1.5 [8]. In the last
10 years, 12 epidemiological studies on cancer after low-
dose rate, moderate-dose exposures were included in
the analysis of cancer risk related to such exposures
[74], and the excess relative risk per dose values were
Figure 6 The dose-effect relationship between radiation exposure and cancer. The solid line indicates the epidemiological evidence, which
is conclusive for doses above 50 to 100 mSv. The dashed line indicates the dose range with absent or inconclusive evidence.
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Page 10 of 13greater than those published by BEIR VII and ICRP. In
addition, the possibility of non-cancer health effects cur-
rently not accepted in the radioprotection regulating fra-
mework are considered increasingly likely, for instance
for atherosclerotic effects, proven on epidemiological
grounds for doses higher than 500 mSv [40]. According
to ICRP, a dose of 500 mSv may lead to approximately
1% of exposed individuals developing cardiovascular or
cerebrovascular disease, more than 10 years after the
exposure, in addition to the 30-50% suffering from dis-
ease independently of the exposure [40]. Cardiologists,
researchers and scientific societies should make every
effort to move from the current evidence-poor to an evi-
dence-rich milieu, with data directly linking radiation
exposure to cancer and non-cancer effects in our
patients and in ourselves as exposed population. In the
meantime, the adoption of BEIR VII or ICRP estimates -
a prudent trade-off between scientific evidence and jud-
gement, and therefore more likely to fall on the conser-
vative side of risk estimate – is recommended.
Conclusions
In the recent past, sometimes cardiologists have been
unaware of the radiological dose of the examination
they prescribe or practice, but they should make every
effort to reduce unnecessary radiation exposure from
medical imaging. This is best obtained through a sys-
tematic implementation of the 3A’ss t r a t e g yp r o p o s e d
by the International Atomic Energy Agency in 2011:
Audit (of true delivered dose); Appropriateness (since at
least one-third of examinations are inappropriate);
Awareness (since the knowledge of doses and risks is
still largely suboptimal in doctors and patients) [75]. It
can be repeated for imaging and invasive cardiologists
what has been recently written of radiologists: “they
must walk a digital tightrope strung between too much
and too little radiation. they must image gently, but not
too gently - striking a balance between patient risk and
diagnostic value” [76]. The recognition of risks inherent
in the use of a known carcinogen such as radiation also
opens unprecedented new opportunities for scientific
[77], social, technological, bioethics [78,79] and medical
advancement, of interest to scientists, clinical cardiolo-
gists, patients, and industry [80]. A good cardiologist -
and even more so, a good imaging or interventional car-
diologist - cannot be afraid of radiation, but must be
very afraid of radiation unawareness.
Acknowledgements
This work has received financial support from the Istituto Toscana Tumori -
progetto SUIT-Heart (stop Useless Imaging Testing in Heart Disease).
Author details
1Institute of Clinical Physiology, CNR, Pisa, Italy.
2San Carlos University
Hospital, Complutense University of Madrid, Madrid, Spain.
Authors’ contributions
EP drafted the manuscript. EV critically reviewed it, and also wrote parts
related to dosimetry. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 October 2011 Accepted: 21 November 2011
Published: 21 November 2011
References
1. Picano E: Stress echocardiography: a historical perspective. Am J Med
2003, 114:126-30, Special Article.
2. Picano E: Sustainability of medical imaging. BMJ 2004, 328:578-80,
Education and Debate.
3. Picano E: Informed consent and communication of risk from radiological
and nuclear medicine examinations: how to escape from a
communication inferno. BMJ 2004, 329:849-851, Education and debate.
4. Council Directive 97/43/Euratom of 30 June 1997 on health protection
of individuals against the dangers of ionising radiation in relation to
medical exposure, and repealing Directive 84/466/Euratom. Official
Journal of the European Communities 1997, L 180:0022-7.
5. European Commission on Radiation Protection 118: Referral guidelines
for imaging. [http://ec.europa.eu/energy/nuclear/radioprotection/
publication/doc/118_en.pdf], (last accessed September 21, 2011).
6. Berrington de Gonzalez A, Kim KP, Smith-Bindman R, McAreavey D:
Myocardial perfusion scans: projected population cancer risks from
current levels of use in the United States. Circulation 2010, 122:2403-10.
7. Abbott BG, Zaret BL: Contemporary cardiology and hysteric
nucleophobia. Am J Med 2003, 114:131-4.
8. Committee to Assess Health Risks from Exposure to Low Levels of
Ionizing Radiation. Health risks from exposure to low levels of ionizing
radiation: BEIR VII Phase 2. Washington, DC: The National Academies
Press; 2006. [http://www.nap.edu/openbook.php?isbn=030909156X],
Available at: Last accessed September 21, 2011.
9. The 2007 Recommendations of the International Commission on
Radiological Protection. Publication 103. Ann ICRP 2007, 37:1-332.
10. UNSCEAR 2008 Report: “Sources and effects of ionizing radiation”.I.
11. Brindis RG, Douglas PS, Hendel RC, Peterson ED, Wolk MJ, Allen JM,
Patel MR, Raskin IE, Hendel RC, Bateman TM, Cerqueira MD, Gibbons RJ,
Gillam LD, Gillespie JA, Hendel RC, Iskandrian AE, Jerome SD, Krumholz HM,
Messer JV, Spertus JA, Stowers SA, American College of Cardiology
Foundation Quality Strategic Directions Committee Appropriateness Criteria
Working Group, American Society of Nuclear Cardiology, American Heart
Association: ACCF/ASNC appropriateness criteria for single-photon
emission computed tomography myocardial perfusion imaging (SPECT
MPI): a report of the American College of Cardiology Foundation Quality
Strategic Directions Committee Appropriateness Criteria Working Group
and the American Society of Nuclear Cardiology endorsed by the
American Heart Association. J Am Coll Cardiol 2005, 46:1587-605.
12. Hirshfeld JW Jr, Balter S, Brinker JA, Kern MJ, Klein LW, Lindsay BD,
Tommaso CL, Tracy CM, Wagner LK: ACCF/AHA/HRS/SCAI Clinical
Competence Statement on Physician Knowledge to Optimize Patient
Safety and Image Quality in Fluoroscopically Guided Invasive
Cardiovascular Procedures: A Report of the American College of
Cardiology Foundation/American Heart Association/American College of
Physicians Task Force on Clinical Competence and Training. Circulation
2005, 111:511-532.
13. Gerber TC, Carr JJ, Arai AE, Dixon RL, Ferrari VA, Gomes AS, Heller GV,
McCollough CH, McNitt-Gray MF, Mettler FA, Mieres JH, Morin RL,
Yester MV: Ionizing radiation in cardiac imaging: a science advisory from
the American Heart Association Committee on Cardiac Imaging of the
Council on Clinical Cardiology and Committee on Cardiovascular
Imaging and Intervention of the Council on Cardiovascular Radiology
and Intervention. Circulation 2009, 119:1056-65.
14. Brindis R, Douglas PS: President’s page: The ACC encourages multi-
pronged approach to radiation safety. J Am Coll Cardiol 2010, 56:522-4.
15. Food and Drug Administration White Paper: Initiative to Reduce
Unnecessary Radiation Exposure from Medical Imaging. Initiative to
reduce unnecessary radiation exposure. [http://www.fda.gov/Radiation-
Picano and Vano Cardiovascular Ultrasound 2011, 9:35
http://www.cardiovascularultrasound.com/content/9/1/35
Page 11 of 13EmittingProducts/RadiationSafety/RadiationDoseReduction/ucm199994.
htm]].
16. Mettler FA Jr, Bhargavan M, Faulkner K, Gilley DB, Gray JE, Ibbott GS,
Lipoti JA, Mahesh M, McCrohan JL, Stabin MG, Thomadsen BR,
Yoshizumi TT: Radiologic and nuclear medicine studies in the United
States and worldwide: frequency, radiation dose, and comparison with
other radiation sources–1950-2007. Radiology 2009, 253:520-31.
17. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K,
Einstein AJ, Nallamothu BK: Exposure to low-dose ionizing radiation from
medical imaging procedures. N Engl J Med 2009, 361:849-57.
18. Hacker M, Schnell-Inderst P, Nosske D, Weiss M, Stamm-Meyer A, Brix G,
Hahn K: Radiation exposure of patients undergoing nuclear medicine
procedures in Germany between 1996 and 2000. Multicenter evaluation
of age and gender-specific patient data. Nuklearmedizin 2005, 44:119-30.
19. Regulla DF, Eder H: Patient exposure in medical X-ray imaging in Europe.
Radiat Prot Dosimetry 2005, 114:11-25.
20. Mettler FA Jr, Huda W, Yoshizumi TT, Mahesh M: Effective doses in
radiology and diagnostic nuclear medicine: a catalog. Radiology 2008,
248:254-63.
21. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ:
Radiation dose to patients from cardiac diagnostic imaging. Circulation
2007, 116:1290-305.
22. Kaufmann PA, Knuuti J: Ionizing radiation risks of cardiac imaging:
estimates of the immeasurable. Eur Heart J 2011, 32:269-71.
23. Suzuki S, Furui S, Issiki T, Kozuma K, Koyama Y, Yamamoto H, Ochai M,
Asakima Y, Ikari Y: Patients’ skin dose during percutaneous intervention
for chronic total occlusion. Cath Cardiov Interv 2008, 71:160-64.
24. Panuccio G, Greenberg RK, Wunderle K, Mastracci TM, Eagleton MG,
Davros W: Comparison of indirect radiation dose estimates with directly
measured radiation dose for patients and operators during complex
endovascular procedures. J Vasc Surg 2011, 53:885-894.e1, discussion 894.
25. Signorotto P, Del Vecchio A, Montorfano M, Maisano F, Giagnorio M,
Bellanca R, Colombo A, Calandrino R: Dosimetric data and radiation risk
analysis for new procedures in interventional cardiology. Radiat Prot
Dosimetry 2010.
26. Miller DL, Vañó E, Bartal G, Balter S, Dixon R, Padovani R, Schueler B,
Cardella JF, de Baère T, Cardiovascular and Interventional Radiology Society
of Europe, Society of Interventional Radiology: Occupational radiation
protection in interventional radiology: a joint guideline of the
Cardiovascular and Interventional Radiology Society of Europe and the
Society of Interventional Radiology. Cardiovasc Intervent Radiol 2010,
33:230-9.
27. Vano E: Radiation exposure to cardiologists: how it could be reduced.
Heart 2003, 89:1123-4.
28. Venneri L, Rossi F, Botto N, Andreassi MG, Salcone N, Emad A, Lazzeri M,
Gori C, Vano E, Picano E: Cancer risk from professional exposure in staff
working in cardiac catheterization laboratory: insights from the National
Research Council’s Biological Effects of Ionizing Radiation VII Report. Am
Heart J 2009, 157:118-24.
29. Bedetti G, Botto N, Andreassi MG, Traino C, Vano E, Picano E: Cumulative
patient effective dose in cardiology. Br J Radiol 2008, 81:699-705.
30. Ait-Ali L, Andreassi MG, Foffa I, Spadoni I, Vano E, Picano E: Cumulative
patient effective dose and acute radiation-induced chromosomal DNA
damage in children with congenital heart disease. Heart 2010, 96:269-74.
31. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL,
Moses JW, Balter S: Multiple testing, cumulative radiation dose, and
clinical indications in patients undergoing myocardial perfusion
imaging. JAMA 2010, 304:2137-44.
32. Kaul P, Medvedev S, Hohmann SF, Douglas P, Peterson ED, Patel MR:
Ionizing radiation exposure to patients admitted with acute myocardial
infarction in the United States. Circulation 2010, 122:2160-69.
33. Kuon E: Radiation exposure in invasive cardiology. Heart 2008, 94:667-74.
34. Padovani R, Le Heron J, Cruz-Suarez R, Duran A, Lefaure C, Miller DL,
Sim HK, Vano E, Rehani M, Czarwinski R: International project on individual
monitoring and radiation exposure levels in interventional cardiology.
Radiat Prot Dosimetry 2011, 144:437-41.
35. Klein LW, Miller DL, Balter S, Laskey W, Haines D, Norbash A, Mauro MA,
Goldstein JA, Joint Inter-Society Task Force on Occupational Hazards in the
Interventional Laboratory: Occupational health hazards in the
interventional laboratory: time for a safer environment. J Vasc Interv
Radiol 2009, 20:S278-83.
36. Vaño E, Gonzalez L, Fernandez JM, Alfonso F, Macaya C: Occupational
radiation doses in interventional cardiology: a 15-year follow-up. Br J
Radiol 2006, 79:383-8.
37. Watson RM: Radiation exposure: clueless in the cath lab, or sayonara
ALARA. Cathet Cardiovasc Diagn 1997, 42:126-7.
38. Correia MJ, Hellies A, Andreassi MG, Ghelarducci B, Picano E: Lack of
radiological awareness among physicians working in a tertiary-care
cardiological centre. Int J Cardiol 2005, 103:307.
39. Kim C, Vasaiwala S, Haque F, Pratap K, Vidovich MI: Radiation safety
among cardiology fellows. Am J Cardiol 2010, 106:125-8.
40. Annals of the ICRP: Early and late effects of radiation in normal tissues
and organs: threshold doses for tissue reactions and other non-cancer
effects of radiation in a radiation protection context. Draft report for
consultation ICRP ref 4834-1783-0153 2011, 2.
41. Rehani MM, Vano E, Ciraj-Bjelac O, Kleiman NJ: Radiation and cataract.
Radiat Prot Dosimetry 2011.
42. Vano E, Kleiman NJ, Duran A, Rehani MM, Echeverri D, Cabrera M: Radiation
cataract risk in interventional cardiology personnel. Radiat Res 2010,
174:490-495.
43. Ciraj-Bjelac O, Rehani MM, Sim KH, Liew HB, Vano E, Kleiman NJ: Risk for
radiationinduced cataract for staff in interventional cardiology: is there
reason for concern? Catheter Cardiovasc Interv 2010, 76:826-834.
44. ICRP Statement on Tissue Reactions. Approved by the Commission on
April 21, 2011. [http://www.icrp.org/docs/ICRP%20Statement%20on%
20Tissue%20Reactions].
45. Balter S, Hopewell JW, Miller DL, Wagner LK, Zelefsky MJ: Fluoroscopically
guided interventional procedures: a review of radiation effects on
patients’ skin and hair. Radiology 2010, 254:326-41.
46. Vlietstra RE, Wagner LK: X-ray burns–painful, protracted, and preventable.
Clin Cardiol 2008, 31:145-7.
47. Rehani MM, Srimahachota S: Skin injuries in interventional procedures.
Radiation Protection Dosimetry 2011, 1-5.
48. SAFRAD - SAFety in RADiological procedures. [http://rpop.iaea.org/safrad].
49. Land CE: Estimating cancer risks from low doses of ionizing radiation.
Science 1980, 209:1197-203.
50. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH,
Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB,
Zaider M: Cancer risks attributable to low doses of ionizing radiation:
assessing what we really know. Proc Natl Acad Sci USA 2003, 100:1376-6.
51. Eisenberg MJ, Afilalo J, Lawler PR, Abrahamowicz M, Richard H, Pilote L:
Cancer risk related to low-dose ionizing radiation from cardiac imaging
in patients after acute myocardial infarction. CMAJ 2011, 183:430-6.
52. Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H: Gamma-H2AX foci
as a biomarker for patient X-ray exposure in pediatric cardiac
catheterization: are we underestimating radiation risks? Circulation 2009,
120:1903-9.
53. Vasan RS: Biomarkers of cardiovascular disease. Molecular basis and
practical considerations. Circulation 2010, 113:2335-62.
54. Andreassi MG, Cioppa A, Manfredi S, Palmieri C, Botto N, Picano E: Acute
chromosomal DNA damage in human lymphocytes after radiation
exposure in invasive cardiovascular procedures. Eur Heart J 2007,
28:2195-9.
55. Andreassi MG, Ait-Ali L, Botto N, Manfredi S, Mottola G, Picano E: Cardiac
catheterization and long-term chromosomal damage in children with
congenital heart disease. Eur Heart J 2006, 27:2703-8.
56. Andreassi MG, Cioppa A, Botto N, Joksic G, Manfredi S, Federici C, Ostojic M,
Rubino P, Picano E: Somatic DNA damage in interventional cardiologists:
a case-control study. FASEB J 2005, 19:998-9.
57. Russo GL, Tedesco I, Russo M, Cioppa A, Andreassi MG, Picano E: Cellular
adaptation to chronic radiation exposure in interventional cardiologists.
Eur Heart J 2011.
58. Andreassi MG, Foffa I, Manfredi S, Botto N, Cioppa A, Picano E: Genetic
polymorphisms in XRCC1, OGG1, APE1 and XRCC3 DNA repair genes,
ionizing radiation exposure and chromosomal DNA damage in
interventional cardiologists. Mutat Res 2009, 666:57-63.
59. Andreassi MG, Cioppa A, Manfredi S, Neri MG, Foffa I, Picano E: N-acetyl
cysteine reduces chromosomal DNA damage in circulating lymphocytes
during cardiac catheterization procedures: A pilot study. Int J Cardiol
2011.
60. Gahadri JR, Küest SM, Goetti R, et al: Image quality and radiation dose
comparison of prospectively triggered low-dose CCTA: 128-slice dual-
Picano and Vano Cardiovascular Ultrasound 2011, 9:35
http://www.cardiovascularultrasound.com/content/9/1/35
Page 12 of 13source high-pitch spiral versus 64-slice single-source sequential
acquisition. Int J Cardiovasc Imaging 2011.
61. Picano E, Pasanisi E, Brown J, Marwick TH: A gatekeeper for the
gatekeeper: inappropriate referrals to stress echocardiography. Am Heart
J 2007, 154:285-90.
62. Gibbons RJ, Miller TD, Hodge D, Urban L, Araoz PA, Pellikka P, McCully RB:
Application of appropriateness criteria to stress single-photon emission
computed tomography sestamibi studies and stress echocardiograms in
an academic medical center. J Am Coll Cardiol 2008, 51:1283-9.
63. Ayyad AE, Cole J, Syed A, Desai MY, Halliburton S, Schoenhagen P,
Flamm SD, Sola S: Temporal trends in utilization of cardiac computed
tomography. J Cardiovasc Comput Tomogr 2009, 3:16-21.
64. President’s Cancer Panel: Environmentally caused cancers are “grossly
underestimated” and “needlessly devastate American lives”. [http://www.
environmentalhealthnews.org/ehs/news/presidents-cancer-panel].
65. Sidhu M, Coley BD, Goske MJ, Connolly B, Racadio J, Yoshizumi TT, Utley T,
Strauss KJ: Image Gently, Step Lightly: increasing radiation dose
awareness in pediatric interventional radiology. Pediatr Radiol 2009,
39:1135-8.
66. Carpeggiani C, Paterni M, Caramella D, Vano E, Semelka R, Picano E: A
novel tool for user-friendly estimation of natural, diagnostic and
professional radiation risk: Radio-Risk software. Eur J Radiology 2011.
67. Linet MS, Kim KP, Miller DL, Kleinerman RA, Simon SL, Berrington de
Gonzalez A: Historical review of occupational exposures and cancer risks
in medical radiation workers. Radiat Res 2010, 174:793-808.
68. Upton AC, Adelstein SJ, Brenner DJ, et al: Report No. 136–Evaluation of
the Linear-Nonthreshold Dose-Response Model for Ionizing Radiation.
Bethesda, MD: National Council on Radiation Protection and Measurements
(NCRP) 2001.
69. Cox R, Muirhead CR, Stather JW, Edwards AA, Little MP: Risk of radiation-
induced cancer at low doses and low dose rates for radiation protection
purposes. Documents of the NRPB 1995, 6:1-77.
70. Health Physics Society. Radiation risk in perspective: Position statement
of the Health Physics Society. 2004 [http://hps.org/documents/
radiationrisk.pdf], Adopted January 1996, revised Accessed June 14, 2007.
71. Tubiana M, Aurengo A, Averbeck D, et al: Dose-effect relationships and
estimation of the carcinogenic effects of low doses of ionizing radiation.
2005 [http://www.academie-medecine.fr/upload/base//
rapports_227_fichier_lie.rtf], Accessed June 14, 2007.
72. American Nuclear Society: Health effects of low-level radiation: position
statement. 2001 [http://www.ans.org/pi/ps/docs/ps41.pdf], Accessed June
14, 2007.
73. Einstein AJ, Henzlova MJ, Rajagopalan S: Estimating risk of cancer
associated with radiation exposure from 64-slice computed tomography
coronary angiography. JAMA 2007, 298:317-23.
74. Jacob P, Rühm W, Walsh L, Blettner M, Hammer G, Zeeb H: Is cancer risk
of radiation workers larger than expected? Occup Environ Med 2009,
66:789-96.
75. Malone J, Guleria R, Craven C, Horton P, Järvinen H, Mayo J, O’reilly G,
Picano E, Remedios D, Leheron J, Rehani M, Holmberg O, Czarwinski R:
Justification of diagnostic medical exposures, some practical issues:
report of an International Atomic Energy Agency Consultation. Br J
Radiol 2011.
76. Freihen GT: New technologies promise dramatic cuts in CT dose. 2011,
Medscape cardiology news. Medpulse newsletter.
77. Gori T, Münzel T: Biological effects of low-dose radiation: of harm and
hormesis. Eur Heart J 2011, Editorial.
78. Picano E, Matucci-Cerinic M: Unnecessary radiation exposure from
medical imaging in rheumatology patients. Rheumatology 2011,
50:1537-39.
79. Baerlocher MO, Detski AS: Discussing radiation risks associated with CT
scans with patients. JAMA 2010, 304:2170-2171.
80. Limacher MC, Zaher CA, Walsh MN, Wolf WJ, Douglas PS, Schwartz JB,
Wright JS, Bodycombe DP: The ACC professional life survey: career
decisions of women and men in cardiology. A report of the Committee
on Women in Cardiology. American College of Cardiology. J Am Coll
Cardiol 1998, 32:827-35.
doi:10.1186/1476-7120-9-35
Cite this article as: Picano and Vano: The Radiation Issue in Cardiology:
the time for action is now. Cardiovascular Ultrasound 2011 9:35.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Picano and Vano Cardiovascular Ultrasound 2011, 9:35
http://www.cardiovascularultrasound.com/content/9/1/35
Page 13 of 13